[Oral clonidine test for growth hormone release (author's transl)]. 1981

F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García

Serum growth hormone (GH) was determined in 15 children (three with normal height, one with pituitary dwarfism, and eleven with short stature without endocrinological disturb) after oral clonidine load of 0,15 mg/m2 S.A. Significant GH increase was observed, as other authors have reported. Authors findings confirm that clonidine is a potent stimulus for growth hormone release, without relevant side effects. In two children with short stature without endocrinological disturb, there was a partial failure to increase GH in response to clonidine. Authors conclude that confirmation of GH deficiency in the case of failure to respond to oral clonidine test requires one other stimulation test.

UI MeSH Term Description Entries
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D004393 Dwarfism, Pituitary A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development. Growth Hormone Deficiency Dwarfism,Hypophysial Dwarf,Hyposomatotrophic Dwarfism,Pituitary Dwarf,Dwarfism, Growth Hormone Deficiency,Isolated GH Deficiency,Isolated Growth Hormone Deficiency,Isolated HGH Deficiency,Isolated Human Growth Hormone Deficiency,Isolated Somatotropin Deficiency,Isolated Somatotropin Deficiency Disorder,Nanism, Pituitary,Pituitary Dwarfism,Pituitary Nanism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
January 1981, Helvetica paediatrica acta,
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
August 1979, Lancet (London, England),
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
December 1979, Lancet (London, England),
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
October 1989, Indian pediatrics,
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
September 1982, Acta paediatrica Scandinavica,
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
January 1982, Panminerva medica,
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
January 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
January 1985, American journal of diseases of children (1960),
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
December 1993, Journal of endocrinological investigation,
F Moreno Romero, and A Aparicio Palomino, and J Espinosa Ruiz-Cabal, and J Cruz Ortega, and F Requena Guerrero, and J J Cardesa García
September 1983, The Journal of pediatrics,
Copied contents to your clipboard!